Amphastar Pharmaceuticals Inc - רווח למניה לשנה מתגלגלת AMPH

Amphastar Pharmaceuticals (AMPH) generates revenue through the production of complex injectable generics, where high barriers to entry ensure stable margins. Management has established effective vertical integration to control costs. This daily price action of EPS YoY TTM on the GURU.Markets platform chart shows that the current value is -4.20. Business growth is further supplemented by the acquisition of rights to finished drugs from corporate behemoths.
AMPH (amphastar.com): פילוחים אנליטיים ודוחות לפי אינדיקטורים

Steady demand for scarce injectable generics from Amphastar Pharmaceuticals (AMPH) creates a foundation for the stable expansion of net income. By analyzing the current EPS YoY TTM trajectory, an investor assesses the rolling annual growth rate of earnings per share, which allows for the identification of long-term profitability trends and the timely recognition of the risk of overpaying for the asset in the event of excessive metric growth.